CERO THERAPEUTICS HOLDINGS, INC. Other Executive Compensation Disclosures
Every other executive-compensation XBRL fact the company filed (policies, award timing, footnotes, adjustments), newest first. Long text is shortened; the filing has the full text.
- 2026-08-14: Disclosure Non Rule10b51Arr Adopted; Period 2026-04-01..2026-06-30; Value No.
- 2026-08-14: Disclosure Rule10b51Arr Adopted; Period 2026-04-01..2026-06-30; Value No.
- 2026-08-14: Disclosure Non Rule10b51Arr Terminated; Period 2026-04-01..2026-06-30; Value No.
- 2026-08-14: Disclosure Rule10b51Arr Terminated; Period 2026-04-01..2026-06-30; Value No.
| Filed | Disclosure | Qualifiers | Period | Value |
|---|---|---|---|---|
| 2026-08-14 10-Q | Non Rule10b51Arr Adopted | 2026-04-01..2026-06-30 | No | |
| 2026-08-14 10-Q | Rule10b51Arr Adopted | 2026-04-01..2026-06-30 | No | |
| 2026-08-14 10-Q | Non Rule10b51Arr Terminated | 2026-04-01..2026-06-30 | No | |
| 2026-08-14 10-Q | Rule10b51Arr Terminated | 2026-04-01..2026-06-30 | No | |
| 2026-05-15 10-Q | Non Rule10b51Arr Adopted | 2026-01-01..2026-03-31 | No | |
| 2026-05-15 10-Q | Rule10b51Arr Adopted | 2026-01-01..2026-03-31 | No | |
| 2026-05-15 10-Q | Non Rule10b51Arr Terminated | 2026-01-01..2026-03-31 | No | |
| 2026-05-15 10-Q | Rule10b51Arr Terminated | 2026-01-01..2026-03-31 | No | |
| 2026-04-15 10-K | Rule10b51Arr Terminated | 2025-10-01..2025-12-31 | No | |
| 2026-04-15 10-K | Non Rule10b51Arr Terminated | 2025-10-01..2025-12-31 | No | |
| 2026-04-15 10-K | Rule10b51Arr Adopted | 2025-10-01..2025-12-31 | No | |
| 2026-04-15 10-K | Non Rule10b51Arr Adopted | 2025-10-01..2025-12-31 | No | |
| 2025-11-28 DEF 14A | Err Compensation Analysis | RestatementDate: 2024-12-31 | 2024-01-01..2024-12-31 | Awards granted under the Amended Plan are subject to recoupment in accordance with any clawback policy adopted by the Board. |
| 2025-11-19 10-Q | Non Rule10b51Arr Adopted | 2025-07-01..2025-09-30 | No | |
| 2025-11-19 10-Q | Rule10b51Arr Adopted | 2025-07-01..2025-09-30 | No | |
| 2025-11-19 10-Q | Non Rule10b51Arr Terminated | 2025-07-01..2025-09-30 | No | |
| 2025-11-19 10-Q | Rule10b51Arr Terminated | 2025-07-01..2025-09-30 | No | |
| 2025-08-22 10-Q | Non Rule10b51Arr Adopted | 2025-04-01..2025-06-30 | No | |
| 2025-08-22 10-Q | Rule10b51Arr Adopted | 2025-04-01..2025-06-30 | No | |
| 2025-08-22 10-Q | Non Rule10b51Arr Terminated | 2025-04-01..2025-06-30 | No | |
| 2025-08-22 10-Q | Rule10b51Arr Terminated | 2025-04-01..2025-06-30 | No | |
| 2025-05-15 10-Q | Non Rule10b51Arr Adopted | 2025-01-01..2025-03-31 | No | |
| 2025-05-15 10-Q | Rule10b51Arr Adopted | 2025-01-01..2025-03-31 | No | |
| 2025-05-15 10-Q | Non Rule10b51Arr Terminated | 2025-01-01..2025-03-31 | No | |
| 2025-05-15 10-Q | Rule10b51Arr Terminated | 2025-01-01..2025-03-31 | No | |
| 2025-05-07 DEF 14A | Err Compensation Analysis | RestatementDate: 2024-12-31 | 2024-01-01..2024-12-31 | Awards granted under the Amended Plan are subject to recoupment in accordance with any clawback policy adopted by the Board. |
| 2025-05-07 DEF 14A | Non Rule10b51Arr Adopted | 2024-10-01..2024-12-31 | No | |
| 2025-05-07 DEF 14A | Rule10b51Arr Adopted | 2024-10-01..2024-12-31 | No | |
| 2025-05-07 DEF 14A | Non Rule10b51Arr Terminated | 2024-10-01..2024-12-31 | No | |
| 2025-05-07 DEF 14A | Rule10b51Arr Terminated | 2024-10-01..2024-12-31 | No | |
| 2025-05-07 DEF 14A | Insider Trading Policies Proc Adopted | 2024-01-01..2024-12-31 | Yes | |
| 2025-05-07 DEF 14A | Award Timing MNPI Disclosure | 2024-01-01..2024-12-31 | Our compensation committee has generally granted equity awards on an annual basis and when it has determined necessary or appropriate for retention and recruitment, including following the successful completion of major corporate transactions or regulatory milestones. In addition, eligible employees… | |
| 2025-05-07 DEF 14A | Award Timing Predetermined | 2024-01-01..2024-12-31 | Yes | |
| 2025-05-07 DEF 14A | Award Timing How MNPI Considered | 2024-01-01..2024-12-31 | During 2024, our compensation committee did not take into account any material nonpublic information when determining the timing and terms of equity incentive awards, and we did not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation… | |
| 2025-05-07 DEF 14A | MNPI Disclosure Timed For Compensation Val | 2024-01-01..2024-12-31 | No | |
| 2025-05-07 DEF 14A | Award Timing Method | 2024-01-01..2024-12-31 | During 2024, we did not grant stock options to our named executive officers during any period beginning four business days before and ending one business day after the filing or furnishing of a Form 10 -Q , 10 -K or 8 -K that discloses material nonpublic information. | |
| 2025-05-07 DEF 14A | Award Timing MNPI Considered | 2024-01-01..2024-12-31 | No | |
| 2025-04-15 10-K | Insider Trading Policies Proc Adopted | 2024-01-01..2024-12-31 | Yes | |
| 2025-04-15 10-K | Non Rule10b51Arr Adopted | 2024-01-01..2024-12-31 | No | |
| 2025-04-15 10-K | Rule10b51Arr Adopted | 2024-01-01..2024-12-31 | No | |
| 2025-04-15 10-K | Non Rule10b51Arr Terminated | 2024-01-01..2024-12-31 | No | |
| 2025-04-15 10-K | Rule10b51Arr Terminated | 2024-01-01..2024-12-31 | No | |
| 2024-08-14 10-Q | Non Rule10b51Arr Adopted | 2024-04-01..2024-06-30 | No | |
| 2024-08-14 10-Q | Rule10b51Arr Adopted | 2024-04-01..2024-06-30 | No | |
| 2024-08-14 10-Q | Non Rule10b51Arr Terminated | 2024-04-01..2024-06-30 | No | |
| 2024-08-14 10-Q | Rule10b51Arr Terminated | 2024-04-01..2024-06-30 | No | |
| 2024-05-17 10-Q | Rule10b51Arr Terminated | 2024-02-14..2024-03-31 | No | |
| 2024-05-17 10-Q | Rule10b51Arr Adopted | 2024-02-14..2024-03-31 | No | |
| 2024-05-17 10-Q | Non Rule10b51Arr Terminated | 2024-02-14..2024-03-31 | No | |
| 2024-05-17 10-Q | Non Rule10b51Arr Adopted | 2024-02-14..2024-03-31 | No | |
| 2024-04-02 10-K | Non Rule10b51Arr Adopted | 2023-10-01..2023-12-31 | No | |
| 2024-04-02 10-K | Rule10b51Arr Adopted | 2023-10-01..2023-12-31 | No | |
| 2024-04-02 10-K | Non Rule10b51Arr Terminated | 2023-10-01..2023-12-31 | No | |
| 2024-04-02 10-K | Rule10b51Arr Terminated | 2023-10-01..2023-12-31 | No |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |